Interactions between leptin and exendin-4, a glucagon-like peptide-1 agonist, in the regulation of food intake in the rat

被引:0
|
作者
Bojanowska, E. [1 ]
Nowak, A. [1 ]
机构
[1] Med Univ Lodz, Inst Gen & Expt Pathol, Dept Behav Pathophysiol, Lodz, Poland
来源
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 2007年 / 58卷 / 02期
关键词
exendin-4; glucagon-like peptide-1; leptin; food intake; water intake;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Leptin interplays with other peptides to control feeding behaviour in humans and animals. Using exendin-4, an agonist of glucagon-like peptide-1, we investigated whether leptin modifies its effect on food intake in the rat. In the first series, exendin-4 alone (0.1, 2 or 10 mu g per rat), leptin alone (0.1, 2, 10 or 100 mu g per rat) or exendin-4 and leptin together (0.1 + 0.1, 2 + 2, 10 + 10, or 2 + 100 mu g per rat, respectively) were injected once intraperitoneally. In the second series animals were injected either with exendin-4 (2 mu g) alone, leptin (10 mu g) alone, or leptin (10 mu g) + exendin-4 (2 mu g) daily for 5 subsequent days. At the lowest dose used, leptin and exendin-4 injected once together, but not separately, reduced significantly a 24-hour food intake. When used in higher doses, however, leptin did not change the exendin-4-dependent suppressory effect on food consumption. No significant differences in food intake were seen between rats treated repeatedly with exendin-4 only and animals injected with both drugs. Hence, leptin and exendin-4 may act additively to inhibit appetite when present in low concentrations while, at high leptin doses, this effect is abolished. The lack of synergistic effects of exendin-4 and high leptin concentrations on food intake may explain, at least in part, mechanisms responsible for leptin resistance in subjects with hyperleptinaemia.
引用
收藏
页码:349 / 360
页数:12
相关论文
共 50 条
  • [31] Role of leptin in the regulation of glucagon-like peptide-1 secretion
    Anini, Y
    Brubaker, PL
    DIABETES, 2003, 52 (02) : 252 - 259
  • [32] Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
    Arakawa, Masayuki
    Mita, Tomoya
    Azuma, Kosuke
    Ebato, Chie
    Goto, Hiromasa
    Nomiyama, Takashi
    Fujitani, Yoshio
    Hirose, Takahisa
    Kawamori, Ryuzo
    Watada, Hirotaka
    DIABETES, 2010, 59 (04) : 1030 - 1037
  • [33] Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line
    Wei, Qian
    Sun, Yu Qiang
    Zhang, Jin
    PEPTIDES, 2012, 37 (01) : 18 - 24
  • [34] Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats
    Liu, Wei Jing
    Jin, Heung Yong
    Lee, Kyung Ae
    Xie, Shu Hua
    Baek, Hong Sun
    Park, Tae Sun
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (05) : 1410 - 1420
  • [35] Inhibition of the Expression of TGF-β1 and CTGF in Human Mesangial Cells by Exendin-4, a Glucagon-like Peptide-1 Receptor Agonist
    Li, Wenbin
    Cui, Meiyu
    Wei, Yong
    Kong, Xianglei
    Tang, Lijun
    Xu, Dongmei
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2012, 30 (03) : 749 - 757
  • [36] Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking
    Lucey, Maria
    Ashik, Tanyel
    Marzook, Amaara
    Wang, Yifan
    Goulding, Joelle
    Oishi, Atsuro
    Broichhagen, Johannes
    Hodson, David J.
    Minnion, James
    Elani, Yuval
    Jockers, Ralf
    Briddon, Stephen J.
    Bloom, Stephen R.
    Tomas, Alejandra
    Jones, Ben
    MOLECULAR PHARMACOLOGY, 2021, 100 (04) : 319 - 334
  • [37] Glucagon-like peptide-1 analogue exendin-4 influence visceral hypersensitivity via PKA pathway
    Zhang, Hongjie
    Cui, Xiufang
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 66 - 67
  • [38] Signalling, trafficking and glucoregulatory properties of glucagon-like peptide-1 receptor agonists exendin-4 and lixisenatide
    Pickford, Philip
    Lucey, Maria
    Fang, Zijian
    Bitsi, Stavroula
    de la Serna, Jorge Bernardino
    Broichhagen, Johannes
    Hodson, David J.
    Minnion, James
    Rutter, Guy A.
    Bloom, Stephen R.
    Tomas, Alejandra
    Jones, Ben
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (17) : 3905 - 3923
  • [39] Differentiating effects of the glucagon-like peptide-1 analogue exendin-4 in a human neuronal cell model
    Luciani, Paola
    Deledda, Cristiana
    Benvenuti, Susanna
    Cellai, Ilaria
    Squecco, Roberta
    Monici, Monica
    Cialdai, Francesca
    Luciani, Giorgia
    Danza, Giovanna
    Di Stefano, Chiara
    Francini, Fabio
    Peri, Alessandro
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (21) : 3711 - 3723
  • [40] EXENDIN-4 IS A SUPER-AGONIST AND EXENDIN (9-39) AMIDE A POTENT ANTAGONIST AT THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR OF INSULINOMA CELLS
    GOKE, R
    ENG, J
    FEHMANN, HC
    GOKE, B
    DIABETES, 1993, 42 : A112 - A112